NIOSH list of antineoplastic and other hazardous drugs in healthcare settings 2012 (supersedes 2010-167).
Connor-TH; MacKenzie-BA; DeBord-DG; Trout-DB
Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 2012-150, 2012 Jun; :1-14
The National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004 (https://www.cdc.gov/niosh/docs/2004-165/
). In Appendix A of the Alert, NIOSH identified a sample list of major hazardous drugs. The list was compiled from information provided by four institutions that have generated lists of hazardous drugs for their respective facilities and by the Pharmaceutical Research and Manufacturers of America (PhRMA) from the American Hospital Formulary Service Drug Information (AHFS DI) monographs [ASHP/AHFS DI 2003]. The 2004 list was updated in 2010; this update adds 26 drugs to the 2010 list. These additions are new drugs or existing drugs that had new warnings from 2007 to 2009. The review process for the addition of the new listings is described in the Federal Register: https://www.cdc.gov/niosh/docket/archive/pdfs/NIOSH-190/0190-080211-frn.pdf
Antineoplastic-agents; Pharmaceuticals; Health-care-personnel; Medical-personnel; Medical-treatment; Pharmaceutical-industry
NTIS Accession No.
(NIOSH) 2012-150; B07092012
Healthcare and Social Assistance
National Institute for Occupational Safety and Health